PCN67 Cost Effectiveness of Zoledronic Acid (ZOL) in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole From German and Italian Perspectives
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1184
https://www.valueinhealthjournal.com/article/S1098-3015(12)01249-1/fulltext
Title :
PCN67 Cost Effectiveness of Zoledronic Acid (ZOL) in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole From German and Italian Perspectives
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01249-1&doi=10.1016/j.jval.2012.03.1184
First page :
A219
Section Title :
Cancer
Open access? :
No
Section Order :
703